Enanta Pharmaceuticals
ENTA
#8930
Rank
NZ$0.18 B
Marketcap
$8.71
Share price
-4.72%
Change (1 day)
-68.87%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - P/B ratio

P/B ratio as of April 2025 : 0.9635

According to Enanta Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 1.61777.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Enanta Pharmaceuticals - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.1410.31%
2023-12-311.03-67.89%
2022-12-313.22-19.38%
2021-12-313.99113.3%
2020-12-311.87-26.3%
2019-12-312.54-21.32%
2018-12-313.23-8.74%
2017-12-313.5348.58%
2016-12-312.381.29%
2015-12-312.35-51.94%
2014-12-314.895.25%
2013-12-314.64
2012-12-31N/A
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
106 10,905.66%๐Ÿ‡บ๐Ÿ‡ธ USA
5.39 459.17%๐Ÿ‡บ๐Ÿ‡ธ USA
7.57 686.15%๐Ÿ‡บ๐Ÿ‡ธ USA
4.71 388.45%๐Ÿ‡บ๐Ÿ‡ธ USA
7.18 645.14%๐Ÿ‡บ๐Ÿ‡ธ USA
5.02 421.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland